Devicare, a company specialising in therapeutic urological solutions which and CataloniaBio & HealhtTech member, has closed an investment round of more than €1.6 million through Capital Cell.
The funding is to accelerate the company’s growth, principally, to enter new markets and to finish the development of the Lit-Control® app.
In total, more than 150 small investors signed up as partners in the company “It is an honour for us here at Device that prestigious endourologists, patients, business angels and the employees themselves support our project” highlights Rosendo Garganta, the founder and CEO of Devicare.
Devicare, with headquarters in the UAB Research Park, has recently announced business agreements in United States, United Kingdom, Malta and Algeria and is now present in 34 countries.
Comments